Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase

Cited by papers we hold 1

• Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.